Skip to main content
logo
Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
2.640
+0.010 (0.38%)
At close: Jul 13, 2026, 4:00 PM EDT
2.689
+0.049 (1.86%)
Pre-market: Jul 14, 2026, 8:07 AM EDT

Acumen Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-113.28-121.34-102.33-52.37-42.86-100.61
Depreciation & Amortization
0.190.180.180.180.170
Stock-Based Compensation
9.779.859.646.153.060.92
Other Adjustments
1.270.88-5.35-0.890.4981.42
Changes in Accounts Payable
0.55-5.094.27-0.260.550.56
Changes in Accrued Expenses
-5.17-1.4310.994.552.013.64
Changes in Other Operating Activities
1.131.4-3.61-0.421.43-3.9
Operating Cash Flow
-105.55-115.54-86.22-43.06-35.15-17.96
Capital Expenditures
-0.01-0.09-0.02-0.02-0.16-0.04
Purchases of Investments
-43.83-38.06-170.73-250.63-41.51-104.08
Proceeds from Sale of Investments
135.28172.08218.7778.9880.86-
Investing Cash Flow
91.44133.9348.03-171.6739.19-104.12
Long-Term Debt Issued
---30--
Net Long-Term Debt Issued (Repaid)
---30--
Issuance of Common Stock
35.890.047.94122.233.91169.19
Repurchase of Common Stock
-0.15-0.07-0.04---
Net Common Stock Issued (Repurchased)
35.74-0.037.9122.233.91169.19
Issuance of Preferred Stock
-----31.28
Net Preferred Stock Issued (Repurchased)
-----31.28
Other Financing Activities
---0.97-0.48--
Financing Cash Flow
35.74-0.036.93151.753.91200.47
Net Cash Flow
21.6418.36-31.26-62.987.9478.39
Free Cash Flow
-105.55-115.63-86.23-43.09-35.31-18
Free Cash Flow Per Share
-1.72-1.91-1.44-0.89-0.87-0.90
Levered Free Cash Flow
-116.6-126.36-90.51-18.34-38.86-100.34
Unlevered Free Cash Flow
-117.93-128.86-102.2-57.11-41.24-19.32
SEC Filings: 10-K · 10-Q